Literature DB >> 4403055

Studies on the site of action of tolbutamide in the lipolytic system.

C Rosak, K M Bartelt, J Beyer, K Schöffling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4403055     DOI： 10.1007/bf01212259

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  14 in total

1.  Some effects of tolbutamide and chlorpropamide in vitro.

Authors:  A E RENOLD; G R ZAHND; B JEANRENAUD; B R BOSHELL
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

2.  [Glycerokinase; isolation and properties of the enzyme].

Authors:  O WIELAND; M SUYTER
Journal:  Biochem Z       Date:  1957

3.  Differentiation of mechanisms of the antilipolytic actions produced by alpha and beta adrenergic blocking agents.

Authors:  S Hynie; G Krishna; B B Brodie
Journal:  Pharmacology       Date:  1969       Impact factor: 2.547

4.  Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells.

Authors:  R W Butcher; C E Baird; E W Sutherland
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

5.  Effects of antilipolytic agents on dibutyryl cyclic AMP induced lipolysis in adipose tissue.

Authors:  M J Peterson; C Patterson; J Ashmore
Journal:  Life Sci       Date:  1968-05-01       Impact factor: 5.037

6.  Theophylline as a tool in studies of the role of cyclic adenosine 3',5'-monophosphate in hormone-induced lipolysis.

Authors:  S Hynie; G Krishna; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

Review 7.  Appraisal of the extrapancreatic actions of sulfonylureas.

Authors:  J M Feldman; H E Lebovitz
Journal:  Arch Intern Med       Date:  1969-03

8.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

9.  Lipolytic effects of cyclic adenosine-3',5'-monophosphate and its butyryl derivatives in vitro, and their inhibition by alpha- and beta-adrenolytics.

Authors:  A Aulich; K Stock; E Westermann
Journal:  Life Sci       Date:  1967-05-01       Impact factor: 5.037

10.  Hormonal regulation of lipolysis and phosphorylase activity in human fat cells.

Authors:  J Moskowitz; J N Fain
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808
View more
  1 in total

1.  Role of calcium and cyclic adenosine 3',5'-monophosphate in the antilipolytic effect of tolbutamide and glibenclamide.

Authors:  R Ebert; O Hillebrandt; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.